12-Month Lobbying Summary - Organization

Servier Canada Inc. / Lucie Rousseau, General Manager

Registration Summary

Currently active - Last Updated: 2024-09-26

Who is lobbying?

Servier Canada Inc. (Address & business activities)

Lucie Rousseau, General Manager

Government Funding

Did Servier Canada Inc. request or receive government funding within the last 12 months? No

Coalition Members Information

Servier Canada Inc. is not a coalition member.

Direct Interests of the Lobbying Activity

Affiliates

Servier Canada Inc. has the following affiliates that could have a direct interest in the outcome of the lobbying activities:

BioFarma S.A (Address information)

Other Affiliates

The activities of Servier Canada Inc. are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking

Contributors with a Direct Interest in the Outcome

No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of Servier Canada Inc.:

What is being lobbied?

Subject Matter of the Lobbying Activities

Details Regarding the Identified Subject Matter

Will any of the lobbyists listed within this registration arrange a meeting between a public office holder and any other individual for the purpose of attempting to influence any of the matters listed below:

Specific Topics of Lobbying Communications	Intended Outcomes	Associated Subject Matters
Engage the BC government Department of Health on Servier's product pipeline and provide perspectives on the policy changes in respect to access of innovative medicines and support of innovation in the life sciences and health products	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Economic Development and Trade, Health
Seek access and reimbursement for Servier products, specifically working with the BC Cancer Agency and the BC Pharmacare program.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Economic Development and Trade, Finances and Budgets, Health

Gifts or benefits provided by the organization

Gifts or Benefits Provided to Public Officer Holders
Name	Gift or Benefit Description	Circumstance	Date Promised	Value Promised	Date Given	Value Given
No Records

Who is being lobbied?

Ministries/Provincial Entities

Health

Who are the lobbyists?

In-house Lobbyists

Lobbyist

Contributions

Raffi Merdkhanian
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No

Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: No

Lucie Rousseau
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No

Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: No

Registration number: 9375-2682
View all registrations versions

Lobbying Activity Reports

What lobbying activities have taken place in the last 12 months?

No monthly Lobbying Activity Reports have been submitted for the last 12 months.

View all Lobbying Activity Reports

Servier Canada Inc. - Address & business activities

Address:

#270 - 3224 avenue Jean-Béraud
Laval, QC H7T 2S4
Canada

Telephone number: 514-296-6064

Contact information in previous versions
- #270 - 3224 avenue Jean-Béraud
  Laval, QC H7T 2S4
  Canada
  
  Telephone number: 450-987-9700 Ext. 4225
- 235 Armand-Frappier
  Laval, QC H7V 4A7
  Canada
  
  Telephone number: 450-987-9700 Ext. 4225
- 235 Armand-Frappier
  Laval, QC H7V 4A7
  Canada
  
  Telephone number: 450-978-0409
- 235 Armand-Frappier
  Laval, QC H7V 4A7
  Canada
  
  Telephone number: 780-982-2469
  
  Fax number: 450-978-4082
- 235 Armand-Frappier
  
  Laval, BC H7V 4A7
  Canada
  
  Telephone number: 780-982-2469
  
  Fax number: 450-978-4082
- 235 Armand-Frappier
  
  Laval, BC H7V 4A7
  Canada
  
  Telephone number: 450-978-0409
  
  Fax number: 450-978-4082
- 235 Armand-Frappier
  
  Laval, QC H7V 4A7
  Canada
  
  Telephone number: 450-978-0409
  
  Fax number: 450-978-4082
- 235 Armand-Frappier
  
  Laval, QC H7V 4A7
  Canada
  
  Telephone number: 450-978-0409

Description of Activities:
Servier Canada Inc. is the Canadian affiliate of The Servier Research Group, an international pharmaceutical company governed by a non-profit foundation, with its global headquarters in France (Suresnes), specializing in ethical pharmaceuticals. With a strong international presence in 149 countries employing more than 21,700 people worldwide, Servier Research Group is entirely independent and reinvests 25% of its turnover from innovative therapies back in to research and development. The mission of Servier Canada is to provide the Canadian medical community and their patients with innovative therapeutic solutions in different therapeutic areas of high unmet needs, like cardiology, diabetes and oncology. Servier Canada collaborates with various stakeholders including researchers, biotech entrepreneurs and innovators. In addition to these partnerships, the Center of Excellence in Clinical Research of Servier Canada is dedicated to clinical development. Servier will not only have innovative new products in its existing therapeutic fields, but will enter at least 3 new therapeutic fields in the coming years. Recently, Servier Canada has received approval for 3 new agents. In the future, Servier Canada will add to the portfolio by making new products available for: the prevention of cardiovascular events, type 2 diabetes, depression, mild cognitive impairment and oncology. For more information please consult : www.servier.ca

Descriptions of the organization's activity in previous versions:
- Servier Canada Inc. is the Canadian affiliate of The Servier Research Group, an international pharmaceutical company governed by a non-profit foundation, with its global headquarters in France (Suresnes), specializing in ethical pharmaceuticals. With a strong international presence in 149 countries employing more than 21,700 people worldwide, Servier Research Group is entirely independent and reinvests 25% of its turnover from innovative therapies back in to research and development. The mission of Servier Canada is to provide the Canadian medical community and their patients with innovative therapeutic solutions in different therapeutic areas of high unmet needs, like cardiology, diabetes and oncology. Servier Canada collaborates with various stakeholders including researchers, biotech entrepreneurs and innovators. In addition to these partnerships, the Center of Excellence in Clinical Research of Servier Canada is dedicated to clinical development. Servier will not only have innovative new products in its existing therapeutic fields, but will enter at least 3 new therapeutic fields in the coming years. Recently, Servier Canada has received approval for 3 new agents. In the future, Servier Canada will add to the portfolio by making new products available for: the prevention of cardiovascular events, type 2 diabetes, depression, mild cognitive impairment and oncology. For more information please consult : www.servier.ca
- Servier Canada Inc. is the Canadian affiliate of The Servier Research Group, an international pharmaceutical company governed by a non-profit foundation, with its global headquarters in France (Suresnes), specializing in ethical pharmaceuticals. With a strong international presence in 148 countries employing more than 21,500 people worldwide, Servier Research Group is entirely independent and reinvests 25% of its turnover from innovative therapies back in to research and development. The mission of Servier Canada is to provide the Canadian medical community and their patients with innovative therapeutic solutions in different therapeutic areas of high unmet needs, like cardiology, diabetes or oncology. Servier Canada collaborates with various stakeholders including researchers, biotech entrepreneurs and innovators. In addition to these partnerships, the Center of Excellence in Clinical Research of Servier Canada is dedicated to clinical development. Servier will not only have innovative new products in its existing therapeutic fields, but will enter at least 3 new therapeutic fields in the coming years. Recently, Servier Canada has received approval for 3 new agents. In the future, Servier Canada will add to the portfolio by making new products available for: the prevention of cardiovascular events, type 2 diabetes, depression, mild cognitive impairment and oncology. For more information please consult : www.servier.ca
- Servier Canada Inc. is the Canadian affiliate of The Servier Research Group, a leading French research based organization, specializing in ethical pharmaceuticals. Servier Canada is committed to the investment in research and development. Looking forward to the future, Servier Canada and the whole Servier Research Group is set for significant growth over the next 10 years. From a product portfolio focused on Cardiovascular and Diabetes, Servier will not only have innovative new products in both of these therapeutic fields, but will enter at least 3 new therapeutic fields in the coming years. Recently, Servier Canada has received approval for 3 new agents. In the future, Servier Canada will add to the portfolio by making new products available for: the prevention of cardiovascular events, type 2 diabetes, depression, mild cognitive impairment and oncology. For more information please consult : www.servier.ca
- Servier Canada Inc. is the Canadian affiliate of The Servier Research Group, a leading French research based organization, specializing in ethical pharmaceuticals. Servier Canada is committed to the investment in research and development. Looking forward to the future, Servier Canada and the whole Servier Research Group is set for significant growth over the next 10 years. From a product portfolio focused on Cardiovascular and Diabetes, Servier will not only have some innovative new products in both of these therapeutic fields, but will enter at least 3 new therapeutic fields in the coming years. In the near future, Servier Canada will make available for patients a portfolio consisting of new and existing products for: hypertension, the prevention of cardiovascular events, type 2 diabetes, depression, mild cognitive impairment and oncology. For more information please consult : www.servier.ca
- Servier Canada Inc. is the Canadian affiliate of The Servier Research Group, a leading French research based organization, specializing in ethical pharmaceuticals. Servier Canada is committed to the investment in research and development. Looking forward to the future, Servier Canada and the whole Servier Research Group is set for significant growth over the next 10 years. From a product portfolio focused on Cardiovascular and Diabetes, Servier will not only have some innovative new products in both of these therapeutic fields, but will enter at least 3 new therapeutic fields in the coming years. In the near future, Servier Canada will make available for patients a portfolio consisting of new and existing products for: hypertension, the prevention of cardiovascular events, type 2 diabetes, depression, mild cognitive impairment and oncology. For more information please consult : www.servier.ca
- Servier Canada Inc. is the Canadian affiliate of The Servier Research Group, a leading French research based organisation, specializing in ethical pharmaceuticals. Servier Canada is committed to the investment in research and development. Looking forward to the future, Servier Canada and the whole Servier Research Group is set for significant growth over the next 10 years. From a product portfolio focused on Cardiovascular and Diabetes, Servier will not only have some innovative new products in both of these therapeutic fields, but will enter at least 3 new therapeutic fields in the coming years. In the near future, Servier Canada will make available for patients a portfolio consisting of new and existing products for: hypertension, the prevention of cardiovascular events, type 2 diabetes, depression, mild cognitive impairment and oncology. For more information please consult : www.servier.ca
- Servier Canada Inc. is the Canadian affiliate of The Servier Research Group, a leading French research based organisation, specializing in ethical pharmaceuticals. Servier Canada is committed to the investment in research and development. Looking forward to the future, Servier Canada and the whole Servier Research Group is set for significant growth over the next 10 years. From a product portfolio focused on Cardiovascular and Diabetes, Servier will not only have some innovative new products in both of these therapeutic fields, but will enter at least 3 new therapeutic fields in the coming years. In the near future, Servier Canada will make available for patients a portfolio consisting of new and existing products for: hypertension, the prevention of cardiovascular events, type 2 diabetes, depression and mild cognitive impairment. For more information please consult : www.servier.ca

Date Modified:: 2024-12-13

Menus

www.lobbyistsregistrar.bc.ca

12-Month Lobbying Summary - Organization

Servier Canada Inc. / Lucie Rousseau, General Manager

Who is lobbying?

Servier Canada Inc. (Address & business activities)

Government Funding

Coalition Members Information

Direct Interests of the Lobbying Activity

Affiliates

Other Affiliates

Contributors with a Direct Interest in the Outcome

What is being lobbied?

Details Regarding the Identified Subject Matter

Gifts or benefits provided by the organization

Who is being lobbied?

Ministries/Provincial Entities

Who are the lobbyists?

What lobbying activities have taken place in the last 12 months?

12-Month Lobbying Summary - Organization

Servier Canada Inc. / Lucie Rousseau, General Manager

Servier Canada Inc. (Address & business activities)

Government Funding

Coalition Members Information

Direct Interests of the Lobbying Activity

Affiliates

Other Affiliates

Contributors with a Direct Interest in the Outcome

Details Regarding the Identified Subject Matter

Gifts or benefits provided by the organization

Ministries/Provincial Entities

Servier Canada Inc. - Address & business activities

Servier Canada Inc. / Lucie Rousseau, General Manager

BioFarma S.A